z-logo
open-access-imgOpen Access
Establishing a service to tackle problematic polypharmacy
Author(s) -
Frances Bennett,
Neha Shah,
Robin E. Offord,
R E Ferner,
Reecha Sofat
Publication year - 2020
Publication title -
future healthcare journal
Language(s) - English
Resource type - Journals
eISSN - 2514-6653
pISSN - 2514-6645
DOI - 10.7861/fhj.2019-0048
Subject(s) - polypharmacy , medicine , deprescribing , interquartile range , drug reaction , adverse effect , primary care , secondary care , emergency medicine , intervention (counseling) , intensive care medicine , drug , family medicine , pharmacology , nursing
Polypharmacy is increasingly common and can increase the risk of adverse drug reactions (ADRs), accounting for a significant proportion of hospital admissions. It may also impair functional status and quality of life. Current efforts to improve polypharmacy take place largely in primary care, but there may be a role for increased support from medicines specialists in the secondary care setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom